MedPath

A study to compare two drugs Dexmedetomidine and Lignocaine to bring down blood pressure, pulse rate, respiratory rate and airway response to endotracheal extubation after CABG(Coronary Artery Bypass Graft) surgery.

Not yet recruiting
Conditions
Chronic ischemic heart disease, unspecified, (2) ICD-10 Condition: O||Medical and Surgical,
Registration Number
CTRI/2021/07/034534
Lead Sponsor
INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES PATNA
Brief Summary

The purpose of study is to compare the efficacy of Dexmedetomidine and lignocaine to attenuate(decrease)the hemodynamic and airway response to endotracheal extubation in elective post operative CABG (coronary artery bypass graft) Surgery

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

(1)ASA 2 and 3 (2)Patient undergoing elective CABG Surgery (3)Mallampati grade 1 and 2.

Exclusion Criteria

(1)Allergy to studied drug (2)Patient with significant valvular heart disease (3)Patient with significant bradycardia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the hemodynamic parameter and airway response1,3,5,7 minutes after drug administration | 1,3,5,10,15,20 minutes after extubation
Secondary Outcome Measures
NameTimeMethod
To assess sedation status of patient and Airway response in form of coughing brochospadm and laryngospasmAt extubation and 1,3,5,10,15,20 minutes after extubation

Trial Locations

Locations (1)

CTVS complex, INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCE PATNA

🇮🇳

Patna, BIHAR, India

CTVS complex, INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCE PATNA
🇮🇳Patna, BIHAR, India
DR MITHILESH KUMAR
Principal investigator
7979822440
mithileshpmc2k10@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.